CAPITOL COUNSEL LLC

Lobbying for AMGEN INC. · Human therapeutics company in the biotechnology industry

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $50,000.00 income · posted Oct 17, 2025

Lobbying activity 1

Medicare/Medicaid

Medicare Part B coverage and reimbursement issues; Medicare Part D coverage issues. AI in health care.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.